Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.63 USD | +1.41% | -10.94% | +45.38% |
Feb. 09 | Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating | MT |
Feb. 07 | Transcript : Enanta Pharmaceuticals, Inc., Q1 2024 Earnings Call, Feb 07, 2024 |
- Stock Market
- Equities
- ENTA Stock
- News Enanta Pharmaceuticals, Inc.